Al Fujairah National Insurance Company P.J.S.C (ADX:AFNIC)
United Arab Emirates · Delayed Price · Currency is AED 210.00
0.00 (0.00%)
At close: Aug 7, 2025, 2:44 PM GST
Revance Therapeutics Income Statement
Financials in millions AED. Fiscal year is January - December.
Millions AED. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Premiums & Annuity Revenue | 570.87 | 420.63 | 282.18 | 231.85 | 166.65 | 206.87 | Upgrade |
Total Interest & Dividend Income | 32.48 | 17.68 | 13.06 | 10.72 | 10.56 | 11.74 | Upgrade |
Gain (Loss) on Sale of Investments | 11.41 | 11.41 | -1.9 | 0.94 | 5.07 | -2.11 | Upgrade |
Other Revenue | -2.73 | - | - | - | 7.92 | 7.52 | Upgrade |
| 612.02 | 449.72 | 293.35 | 243.52 | 190.2 | 224.02 | Upgrade | |
Revenue Growth (YoY) | 85.98% | 53.31% | 20.46% | 28.03% | -15.10% | -6.40% | Upgrade |
Policy Benefits | 556.08 | 415.45 | 289.98 | 248.37 | 87.49 | 93.62 | Upgrade |
Policy Acquisition & Underwriting Costs | -1.43 | - | - | - | 12.7 | 13.04 | Upgrade |
Depreciation & Amortization | 0.55 | 0.55 | 2.99 | 3.66 | - | - | Upgrade |
Selling, General & Administrative | 0.56 | 0.56 | 2.55 | 1.94 | 71.78 | 69.59 | Upgrade |
Provision for Bad Debts | - | - | - | - | 1 | 4 | Upgrade |
Other Operating Expenses | 2.43 | 2.89 | 0.63 | 1.93 | - | - | Upgrade |
Total Operating Expenses | 562.38 | 423.64 | 303.59 | 263.89 | 172.97 | 180.26 | Upgrade |
Operating Income | 49.65 | 26.08 | -10.24 | -20.37 | 17.23 | 43.77 | Upgrade |
Interest Expense | - | - | - | - | -0.15 | -0.24 | Upgrade |
Other Non Operating Income (Expenses) | -0.32 | -0.32 | -0.27 | -0.29 | - | 1.62 | Upgrade |
EBT Excluding Unusual Items | 51.37 | 25.76 | -10.52 | -20.66 | 17.08 | 45.15 | Upgrade |
Gain (Loss) on Sale of Assets | 0.04 | 0.04 | 0.06 | 0.01 | 0.22 | 0.88 | Upgrade |
Asset Writedown | 1.06 | 1.06 | 2.47 | -0.27 | 1.39 | -9.1 | Upgrade |
Pretax Income | 52.47 | 26.86 | -7.98 | -20.91 | 18.69 | 36.93 | Upgrade |
Income Tax Expense | 3.97 | 1.83 | - | - | - | - | Upgrade |
Net Income | 48.5 | 25.03 | -7.98 | -20.91 | 18.69 | 36.93 | Upgrade |
Net Income to Common | 48.5 | 25.03 | -7.98 | -20.91 | 18.69 | 36.93 | Upgrade |
Net Income Growth | 153.59% | - | - | - | -49.41% | 18.32% | Upgrade |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade |
EPS (Basic) | 36.44 | 18.80 | -5.99 | -15.71 | 14.04 | 27.75 | Upgrade |
EPS (Diluted) | 36.44 | 18.80 | -5.99 | -15.71 | 14.04 | 27.75 | Upgrade |
EPS Growth | 153.58% | - | - | - | -49.41% | 18.32% | Upgrade |
Free Cash Flow | 174.42 | 100.67 | 48.81 | 4.14 | 5.38 | 17.66 | Upgrade |
Free Cash Flow Per Share | 131.04 | 75.63 | 36.67 | 3.11 | 4.04 | 13.27 | Upgrade |
Dividend Per Share | - | - | - | - | 10.000 | 13.636 | Upgrade |
Dividend Growth | - | - | - | - | -26.67% | 106.25% | Upgrade |
Operating Margin | 8.11% | 5.80% | -3.49% | -8.37% | 9.06% | 19.54% | Upgrade |
Profit Margin | 7.92% | 5.56% | -2.72% | -8.59% | 9.82% | 16.49% | Upgrade |
Free Cash Flow Margin | 28.50% | 22.38% | 16.64% | 1.70% | 2.83% | 7.88% | Upgrade |
EBITDA | 52.64 | 28.92 | -6.69 | -16.41 | 20.98 | 47.72 | Upgrade |
EBITDA Margin | 8.60% | 6.43% | -2.28% | -6.74% | 11.03% | 21.30% | Upgrade |
D&A For EBITDA | 2.99 | 2.84 | 3.56 | 3.96 | 3.75 | 3.96 | Upgrade |
EBIT | 49.65 | 26.08 | -10.24 | -20.37 | 17.23 | 43.77 | Upgrade |
EBIT Margin | 8.11% | 5.80% | -3.49% | -8.37% | 9.06% | 19.54% | Upgrade |
Effective Tax Rate | 7.56% | 6.83% | - | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.